Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

F.E. van Leeuwen, A.M.J. Chorus, A.W. van den Belt-Dusebout, A. Hagenbeek, R. van Noyon, E.H.M. Kerkhoff, H.M. Pinedo, R. Somers

Research output: Contribution to journalArticleAcademicpeer-review

96 Downloads (Pure)
Original languageEnglish
Pages (from-to)1063-1073
JournalJournal of Clinical Oncology
Volume12
Issue number5
Publication statusPublished - 1994

Cite this